Europe EPA and DHA Market Outlook, 2031
Europe EPA & DHA Market is segmented into By Product Type (EPA, DHA); By Application (Dietary Supplements, Infant Formula, Pharmaceuticals, Food & Beverages, Clinical Nutrition & Medical Foods, Pet Nutrition); By Source (Fish Oil, Algal Oil, Krill Oil, Other Marine Sources).
- Bonafide Research
- 30-10-2026
- Pages : 94
- Figures : 14
- Tables : 30
- Region : Europe
- Category : Food & Beverages
- Food
- Schedule a Call
-
Priyanka Makwana — Research Analyst
The Europe Epa and DHA Market is anticipated to add to more than USD 0.31 Billion by 2026-31.
- Historical Period2020-2024
- Base Year2025
- Forecast Period2026-2031
- Largest MarketGermany
- Fastest Market Italy
- Market Difference(2026-31) USD 0.31 Billion
- Format
Featured Companies
- 1. Basf SE
- 2. Chambal Fertilisers
- 3. Archer-Daniels-Midland Company
- 4. Omega Protein Corporation
- 5. Croda International plc
- 6. Corbion N.V.
- More...
EPA and DHA Market Market Market Analysis
Europe represents an established market for Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA), supported by consumer awareness of omega-3 fatty acids, a developed dietary supplement industry, and demand for specialised nutritional ingredients. Countries such as Germany, the United Kingdom, France, Italy, Spain, and Norway contribute to regional demand through dietary supplements, infant nutrition, pharmaceutical formulations, and functional food products. According to the research report, "Europe EPA and DHA Market Outlook, 2031," published by Bonafide Research, the Europe Epa and DHA Market is anticipated to add to more than USD 0.31 Billion by 2026-31.DHA plays an important role in the European market because of its applications in infant formula, maternal nutrition, dietary supplements, and specialised nutritional products. Its association with brain and visual development supports its incorporation into early-life nutrition formulations. EPA also has established applications in dietary supplements and pharmaceutical products, particularly formulations targeting cardiovascular health and triglyceride management. Manufacturers select these ingredients according to fatty acid concentration, purity, source, and intended application. Demand extends beyond conventional dietary supplements into pharmaceuticals, clinical nutrition, medical foods, functional foods and beverages, and pet nutrition. Manufacturers incorporate EPA and DHA into different product formats, including capsules, softgels, liquid oils, emulsions, and powders. Product development is influenced by consumer preferences, formulation compatibility, ingredient stability, and regulatory requirements across European countries. The European market is influenced by growing interest in preventive healthcare, specialised nutrition, and sustainable ingredient sourcing. Fish oil remains an established source because of its existing marine processing and supply infrastructure. Meanwhile, algae oil is gaining attention among manufacturers developing vegetarian omega-3 supplements, infant nutrition ingredients, and alternative nutritional formulations.
to Download this information in a PDF
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleMarket Dynamics
Market Drivers
• Established Dietary Supplement Industry: Europe has a developed dietary supplement industry supported by consumer interest in preventive healthcare, nutritional wellness, and specialised health products. Omega-3 supplements containing EPA and DHA are available through pharmacies, supermarkets, health stores, and online channels. Food Supplements Europe reports that omega-3 and fish oil products are among the supplements used by European consumers, creating opportunities for ingredient suppliers and finished-product manufacturers.• Growing Demand for Infant Nutrition Ingredients: DHA is an important ingredient in infant nutrition because of its role in early-life brain and visual development. European infant formula manufacturers operate under specific compositional requirements established through EU regulations. These requirements influence ingredient selection, quality control, and product formulation, supporting demand for suitable DHA ingredients across the region.
Market Challenges
• Dependence on Marine Raw Material Supply: Fish oil production depends on marine resource availability, fishing quotas, seasonal landings, and seafood-processing activities. European fish oil production is influenced by the availability of small oily fish and processing by-products. Changes in fishing conditions and international supply can affect procurement costs and ingredient availability for regional manufacturers.• Strict Regulatory and Quality Requirements: EPA and DHA manufacturers must consider European requirements relating to food safety, ingredient composition, contaminants, labelling, and authorised health claims. Infant formula and food supplements are subject to specific regulatory frameworks, creating additional compliance responsibilities for ingredient suppliers and finished-product manufacturers.
Market Trends
• Development of Concentrated Omega-3 Formulations: Ingredient suppliers are focusing on concentrated EPA and DHA oils to serve specialised dietary supplement and pharmaceutical applications. Refining, purification, and concentration technologies allow manufacturers to develop ingredients with specific fatty acid ratios and purity specifications. These developments support product differentiation and application-specific formulations.• Greater Focus on Ingredient Quality and Traceability: European buyers increasingly consider ingredient purity, oxidation stability, contaminants, and sourcing transparency when selecting omega-3 suppliers. Quality frameworks such as the GOED Monograph address oxidative quality, environmental contaminants, and EPA and DHA measurement, supporting standardised quality practices across the omega-3 industry.
EPA and DHA Market Market Segmentation
| By Product Type | Eicosapentaenoic Acid (EPA) | |
| Docosahexaenoic Acid (DHA) | ||
| By Application | Dietary Supplements | |
| Infant Formula | ||
| Pharmaceuticals | ||
| Food & Beverages | ||
| Clinical Nutrition & Medical Foods | ||
| Pet Nutrition | ||
| By Source | Fish Oil | |
| Algae Oil | ||
| Krill Oil | ||
| Other Marine Sources | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Russia | ||
EPA represents the fastest-growing product type segment in the Europe EPA & DHA Market, supported by increasing demand for omega-3 ingredients in cardiovascular health supplements, preventive healthcare, and specialised nutritional formulations. Its expanding applications in dietary supplements and pharmaceutical products are creating additional opportunities across the region. The growth of EPA is supported by increasing consumer awareness of cardiovascular health, healthy ageing, and the role of omega-3 fatty acids in maintaining overall wellbeing. EPA is particularly relevant in nutritional formulations targeting cardiovascular health and healthy triglyceride levels, encouraging manufacturers to develop specialised products with higher EPA concentrations. The established dietary supplement industry across Germany, the United Kingdom, France, Italy, and other European countries provides an important distribution base for these formulations. In addition, the growing preference for preventive healthcare is encouraging consumers to incorporate omega-3 supplements into their regular nutritional routines. Manufacturers are focusing on concentrated EPA oils, improved delivery formats, softgel capsules, liquid supplements, and combination formulations to address different consumer requirements. Pharmaceutical and clinical nutrition applications are also creating opportunities for specialised EPA ingredients, particularly where product formulation requires controlled fatty acid concentrations and consistent ingredient quality. These developments are encouraging suppliers to expand their EPA product portfolios and strengthen their presence in the European nutritional ingredients industry. These factors support EPA as the fastest-growing product type segment in the European market. Pet Nutrition represents the fastest-growing application segment in the Europe EPA & DHA Market, supported by increasing demand for premium pet food, functional nutritional products, and omega-3-enriched animal diets. Its growing applications in specialised pet food, supplements, and functional treats create additional opportunities across the region. The growth of Pet Nutrition is supported by increasing awareness of the benefits of EPA and DHA for animal health, including skin and coat condition, joint health, mobility, and overall wellbeing. The growing trend of pet humanisation is encouraging owners to treat companion animals as family members and invest in products that offer additional nutritional benefits. This is creating demand for premium pet food formulations containing functional ingredients such as fish oil and concentrated omega-3 oils. Countries including Germany, the United Kingdom, France, Italy, and Spain have established pet food industries and growing availability of specialised nutritional products, supporting the adoption of EPA- and DHA-enriched formulations. Manufacturers are incorporating omega-3 ingredients into dry food, wet food, veterinary diets, nutritional supplements, and functional treats to differentiate their products and address specific pet health requirements. In addition, increasing attention to ingredient transparency, nutritional quality, and product functionality is encouraging pet food producers to work with specialised marine ingredient suppliers. The development of customised formulations for different animal life stages and health conditions is further expanding the application of EPA and DHA in pet nutrition. These factors support Pet Nutrition as the fastest-growing application segment in the European market. Fish Oil represents the largest source segment in the Europe EPA & DHA Market, supported by its established production infrastructure, widespread commercial availability, and extensive use across nutritional applications. Its established applications in dietary supplements, infant nutrition, pharmaceuticals, and pet food strengthen its position across the region. The growth of the Fish Oil segment is supported by Europe's established seafood processing industry, marine ingredient supply chain, and long-standing commercial use of fish-derived omega-3 oils. Fish oil is an important raw material for producing EPA- and DHA-rich ingredients, with its suitability across different applications supporting consistent demand from nutritional ingredient manufacturers. Countries such as Denmark play an important role in regional fish oil production, while established processing and trading networks support the movement of marine-derived ingredients across European markets. Fish oil is widely incorporated into dietary supplements, infant nutrition products, pharmaceutical formulations, functional foods, and animal nutrition products because manufacturers can source different grades and concentrations according to their formulation requirements. The availability of refined, concentrated, and purified fish oils also allows suppliers to serve specialised applications that require specific EPA and DHA compositions. Furthermore, established consumer familiarity with fish oil supplements and the presence of experienced ingredient processors support its commercial position in the region. Manufacturers are increasingly focusing on raw material traceability, oxidation control, contaminant management, and sustainable sourcing practices to maintain ingredient quality and meet European regulatory requirements. Although algae oil is gaining attention as an alternative for vegetarian and sustainable omega-3 formulations, fish oil continues to benefit from its established supply infrastructure, broad application base, and commercial availability. These factors support Fish Oil as the largest source segment in the European market.
to Download this information in a PDF
EPA and DHA Market Market Market Regional Insights
Spain is expected to be the fastest-growing country in the Europe EPA & DHA Market, supported by increasing demand for dietary supplements, growing awareness of preventive healthcare, and expanding applications of omega-3 ingredients across nutritional products. The country's developing health and wellness sector is creating opportunities for EPA and DHA suppliers across dietary supplements, functional foods, pharmaceuticals, and pet nutrition. The growth of the EPA & DHA market in Spain is supported by increasing consumer interest in healthy ageing, cardiovascular wellness, and nutritional products that support overall health. Rising awareness of the benefits of omega-3 fatty acids is encouraging consumers to adopt fish oil supplements and other products containing EPA and DHA as part of their regular nutritional routines. The expansion of pharmacies, specialised health stores, online retail platforms, and other supplement distribution channels is improving product accessibility across the country. Spanish manufacturers and international nutrition brands are also expanding their product portfolios through omega-3 capsules, liquid supplements, functional food formulations, and specialised nutritional products. In addition, the development of premium pet food and growing interest in functional animal nutrition are creating further opportunities for EPA and DHA ingredients. These developments, combined with increasing attention to preventive healthcare and product innovation, are expected to support Spain's position as the fastest-growing country market in Europe.
to Download this information in a PDF
Companies Mentioned
- Basf SE
- Chambal Fertilisers
- Archer-Daniels-Midland Company
- Omega Protein Corporation
- Croda International plc
- Corbion N.V.
- Nissui Corporation
- DSM-Firmenich AG
- Epax Norway AS
- Aker BioMarine ASA
- Pharma Marine AS
Table of Contents
- 1. Executive Summary
- 2. Market Dynamics
- 2.1. Market Drivers & Opportunities
- 2.2. Market Restraints & Challenges
- 2.3. Market Trends
- 2.4. Supply chain Analysis
- 2.5. Policy & Regulatory Framework
- 2.6. Industry Experts Views
- 3. Research Methodology
- 3.1. Secondary Research
- 3.2. Primary Data Collection
- 3.3. Market Formation & Validation
- 3.4. Report Writing, Quality Check & Delivery
- 4. Market Structure
- 4.1. Market Considerate
- 4.2. Assumptions
- 4.3. Limitations
- 4.4. Abbreviations
- 4.5. Sources
- 4.6. Definitions
- 5. Economic /Demographic Snapshot
- 6. Europe EPA and DHA Market Outlook
- 6.1. Market Size By Value
- 6.2. Market Share By Country
- 6.3. Market Size and Forecast, By Product Type
- 6.4. Market Size and Forecast, By Application
- 6.5. Market Size and Forecast, By Source
- 6.6. Germany EPA and DHA Market Outlook
- 6.6.1. Market Size by Value
- 6.6.2. Market Size and Forecast By Product Type
- 6.6.3. Market Size and Forecast By Application
- 6.6.4. Market Size and Forecast By Source
- 6.7. United Kingdom (UK) EPA and DHA Market Outlook
- 6.7.1. Market Size by Value
- 6.7.2. Market Size and Forecast By Product Type
- 6.7.3. Market Size and Forecast By Application
- 6.7.4. Market Size and Forecast By Source
- 6.8. France EPA and DHA Market Outlook
- 6.8.1. Market Size by Value
- 6.8.2. Market Size and Forecast By Product Type
- 6.8.3. Market Size and Forecast By Application
- 6.8.4. Market Size and Forecast By Source
- 6.9. Italy EPA and DHA Market Outlook
- 6.9.1. Market Size by Value
- 6.9.2. Market Size and Forecast By Product Type
- 6.9.3. Market Size and Forecast By Application
- 6.9.4. Market Size and Forecast By Source
- 6.10. Spain EPA and DHA Market Outlook
- 6.10.1. Market Size by Value
- 6.10.2. Market Size and Forecast By Product Type
- 6.10.3. Market Size and Forecast By Application
- 6.10.4. Market Size and Forecast By Source
- 6.11. Russia EPA and DHA Market Outlook
- 6.11.1. Market Size by Value
- 6.11.2. Market Size and Forecast By Product Type
- 6.11.3. Market Size and Forecast By Application
- 6.11.4. Market Size and Forecast By Source
- 7. Competitive Landscape
- 7.1. Competitive Dashboard
- 7.2. Business Strategies Adopted by Key Players
- 7.3. Key Players Market Positioning Matrix
- 7.4. Porter's Five Forces
- 7.5. Company Profile
- 7.5.1. DSM-Firmenich AG
- 7.5.1.1. Company Snapshot
- 7.5.1.2. Company Overview
- 7.5.1.3. Financial Highlights
- 7.5.1.4. Geographic Insights
- 7.5.1.5. Business Segment & Performance
- 7.5.1.6. Product Portfolio
- 7.5.1.7. Key Executives
- 7.5.1.8. Strategic Moves & Developments
- 7.5.2. BASF SE
- 7.5.3. Croda International plc
- 7.5.4. KD Pharma Group
- 7.5.5. Corbion N.V.
- 7.5.6. Archer-Daniels-Midland Company
- 7.5.7. Omega Protein Corporation
- 7.5.8. Epax Norway AS
- 7.5.9. Nissui Corporation
- 7.5.10. Pharma Marine AS
- 7.5.11. Aker BioMarine
- 8. Strategic Recommendations
- 9. Annexure
- 9.1. FAQ`s
- 9.2. Notes
- 10. Disclaimer
Table 2: Top 10 Counties Economic Snapshot 2024
Table 3: Economic Snapshot of Other Prominent Countries 2022
Table 4: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 5: Europe EPA and DHA Market Size and Forecast, By Product Type (2025 to 2031F) (In USD Billion)
Table 6: Europe EPA and DHA Market Size and Forecast, By Application (2025 to 2031F) (In USD Billion)
Table 7: Europe EPA and DHA Market Size and Forecast, By Source (2025 to 2031F) (In USD Billion)
Table 8: Germany EPA and DHA Market Size and Forecast By Product Type (2025 to 2031F) (In USD Billion)
Table 9: Germany EPA and DHA Market Size and Forecast By Application (2025 to 2031F) (In USD Billion)
Table 10: Germany EPA and DHA Market Size and Forecast By Source (2025 to 2031F) (In USD Billion)
Table 11: United Kingdom (UK) EPA and DHA Market Size and Forecast By Product Type (2025 to 2031F) (In USD Billion)
Table 12: United Kingdom (UK) EPA and DHA Market Size and Forecast By Application (2025 to 2031F) (In USD Billion)
Table 13: United Kingdom (UK) EPA and DHA Market Size and Forecast By Source (2025 to 2031F) (In USD Billion)
Table 14: France EPA and DHA Market Size and Forecast By Product Type (2025 to 2031F) (In USD Billion)
Table 15: France EPA and DHA Market Size and Forecast By Application (2025 to 2031F) (In USD Billion)
Table 16: France EPA and DHA Market Size and Forecast By Source (2025 to 2031F) (In USD Billion)
Table 17: Italy EPA and DHA Market Size and Forecast By Product Type (2025 to 2031F) (In USD Billion)
Table 18: Italy EPA and DHA Market Size and Forecast By Application (2025 to 2031F) (In USD Billion)
Table 19: Italy EPA and DHA Market Size and Forecast By Source (2025 to 2031F) (In USD Billion)
Table 20: Spain EPA and DHA Market Size and Forecast By Product Type (2025 to 2031F) (In USD Billion)
Table 21: Spain EPA and DHA Market Size and Forecast By Application (2025 to 2031F) (In USD Billion)
Table 22: Spain EPA and DHA Market Size and Forecast By Source (2025 to 2031F) (In USD Billion)
Table 23: Russia EPA and DHA Market Size and Forecast By Product Type (2025 to 2031F) (In USD Billion)
Table 24: Russia EPA and DHA Market Size and Forecast By Application (2025 to 2031F) (In USD Billion)
Table 25: Russia EPA and DHA Market Size and Forecast By Source (2025 to 2031F) (In USD Billion)
Table 26: Competitive Dashboard of top 5 players, 2025
Figure 2: Europe EPA and DHA Market Share By Country (2025)
Figure 3: Germany EPA and DHA Market Size By Value (2025, 2025 & 2031F) (in USD Billion)
Figure 4: United Kingdom (UK) EPA and DHA Market Size By Value (2025, 2025 & 2031F) (in USD Billion)
Figure 5: France EPA and DHA Market Size By Value (2025, 2025 & 2031F) (in USD Billion)
Figure 6: Italy EPA and DHA Market Size By Value (2025, 2025 & 2031F) (in USD Billion)
Figure 7: Spain EPA and DHA Market Size By Value (2025, 2025 & 2031F) (in USD Billion)
Figure 8: Russia EPA and DHA Market Size By Value (2025, 2025 & 2031F) (in USD Billion)
Figure 9: Porter's Five Forces of Global EPA and DHA Market
EPA and DHA Market Market Market Research FAQs
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Our Clients
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (30 October, 2026)
- Notify To Team (30 October, 2026)
- Report updation (31 October, 2026)
- Report Quality Check (31 October, 2026)
- Report Dispatch (01 November, 2026)
- Hard Copy
Recently Viewed Products
Europe EPA and DHA Market Outlook, 2031
We are friendly and approachable, give us a call.